CAPITOLIS LIQUID GLOBAL MARKETS LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 2094379
NEW YORK, NY
Position in ARQT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,110,000
+$1,330,000 QoQ
Shares Held
500,000
0.0% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#43
of 269 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITOLIS LIQUID GLOBAL MARKETS LLC holds $184,208,994 across 8 Biotechnology names. ARQT ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GPCR |
Structure Therapeutics Inc.
|
1,041,100 | $55,875,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
75,000 | $46,765,500 | |
| 3 | CELC |
Celcuity Inc.
|
277,100 | $28,990,202 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
500,000 | $13,110,000 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,249 | $13,038,665 | |
| 6 | INBX |
Inhibrx Biosciences, Inc.
|
119,200 | $11,294,200 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
237,000 | $8,387,430 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
28,000 | $6,747,160 |
All Filings in ARQT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,110,000 | 500,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,780,000 | 500,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||